首页> 美国卫生研究院文献>Evidence-based Complementary and Alternative Medicine : eCAM >Effect of the Combined Extracts of Herba Epimedii and Fructus Ligustri Lucidi on Sex Hormone Functional Levels in Osteoporosis Rats
【2h】

Effect of the Combined Extracts of Herba Epimedii and Fructus Ligustri Lucidi on Sex Hormone Functional Levels in Osteoporosis Rats

机译:淫羊and和山茱F联合提取物对骨质疏松大鼠性激素功能水平的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

The combination of Herba Epimedii and Fructus Ligustri Lucidi has been used to treat osteoporosis for almost 50 years by Professor Shizeng Li, a famous doctor of traditional Chinese medicine (TCM). However, it is unclear whether the combination of the effective constituents of the two herbs may have a protective influence on the skeleton. In the present study, we investigated the effects of the combination extracts of Herba Epimedii and Fructus Ligustri Lucidi on rat model of osteoporosis induced by retinoic acid by gavage. With administrations of the combination extracts of the two herbs (50, 100, and 200 mg/kg/day) via oral gavage for 3 weeks, bone mineral density (BMD), femur histomorphometry, some sex hormones, and sex hormone receptors were measured. Results showed that the combined extracts could increase BMD, affect bone histomorphometry, coordinate the sex hormones at the level of hypothalamus-pituitary-gonad axis, and increase the protein and mRNA expressions of sex hormone receptors. The findings suggested that the combination extracts of Herba Epimedii and Fructus Ligustri Lucidi might be beneficial as an alternative medicine for the prevention and treatment of osteoporosis.
机译:著名的中医(TCM)李世增教授将淫羊Epi和山茱Luc的组合用于治疗骨质疏松症已有近50年的历史了。但是,尚不清楚两种草药的有效成分的组合是否会对骨骼产生保护作用。在本研究中,我们研究了淫羊Epi和山茱ru组合提取物对强饲法维甲酸诱导的骨质疏松大鼠模型的影响。通过口服管饲两种草药的联合提取物(50、100和200μmg/ kg /天),持续3周,测量了骨矿物质密度(BMD),股骨组织形态测量法,一些性激素和性激素受体。结果表明,联合提取物可增加骨密度,影响骨组织形态,在下丘脑-垂体-性腺轴水平上调节性激素,并增加性激素受体的蛋白质和mRNA表达。研究结果表明,淫羊Herb和山茱F的联合提取物可能是预防和治疗骨质疏松症的替代药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号